Inhibition of mutagenicity in Salmonella typhimurium and skin tumor initiating and tumor promoting activities in SENCAR mice by glycyrrhetinic acid: comparison of 18 alpha- and 18 beta-stereoisomers.
Licorice has been used as medicine and as sweetening agent in food products. The major water-soluble constituent of licorice is glycyrrhizin (GL), an oleanane triterpenoide, which is known to be partly hydrolyzed by glucuronidase to its aglycone glycyrrhetinic acid (GA) which exists in 18 alpha (alpha-GA) and 18 beta (beta-GA) stereoisomeric forms. In this study alpha-GA and beta-GA were found to inhibit the mutagenicity of benzo[a]pyrene (B[a]P), 2-aminofluorene and aflatoxin B1 in Salmonella typhimurium TA98 and TA100. beta-GA was more effective than alpha-GA as an antimutagen. In the two-stage skin tumorigenesis protocol using 7,12-dimethylbenz[a]anthracene (DMBA) as the tumor initiating agent followed by twice weekly applications of 12-O-tetradecanoylphorbol-13-acetate as tumor promoter, pretreatment of SENCAR mice with alpha-GA or beta-GA resulted in significant protection against tumor initiation as well as tumor promotion. As an anti-tumor initiating agent, beta-GA was found to be more effective than alpha-GA. Similarly, topical application of beta-GA was found to be more effective than alpha-GA in inhibiting the binding of both [3H]B[a]P and [3H]DMBA to epidermal DNA. However, as an anti-tumor promoter, alpha-GA and beta-GA showed comparable effects. Our results suggest that both alpha-GA and beta-GA possess substantial anti-skin tumor initiating and anti-skin tumor promoting activities.
Wang
Z Y
ZY
Department of Dermatology, Case Western Reserve University, Cleveland, OH.
Agarwal
R
R
Zhou
Z C
ZC
Bickers
D R
DR
Mukhtar
H
H
D000818:Animals; D005260:Female; D006034:Glycyrrhetinic Acid / Q000494:pharmacology* / Q000627:therapeutic use; D008084:Lipoxygenase / Q000378:metabolism; D051379:Mice; D009154:Mutation / Q000187:drug effects; D009955:Ornithine Decarboxylase / Q000378:metabolism; D010105:Oxygenases / Q000378:metabolism; D012486:Salmonella typhimurium / Q000187:drug effects / Q000235:genetics*; D012878:Skin Neoplasms / Q000139:chemically induced / Q000209:etiology / Q000517:prevention & control*; D013237:Stereoisomerism
D010105:Oxygenases; D008084:Lipoxygenase; D009955:Ornithine Decarboxylase; D006034:Glycyrrhetinic Acid